Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
4.580
-0.010 (-0.22%)
At close: Jun 26, 2026, 4:00 PM EDT
4.533
-0.047 (-1.03%)
After-hours: Jun 26, 2026, 5:48 PM EDT
Outset Medical Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Outset Medical stock have an average target of 9.50, with a low estimate of 6.00 and a high estimate of 15. The average target predicts an increase of 107.42% from the current stock price of 4.58.
Analyst Consensus: Buy
* Price targets were last updated on May 8, 2026.
Analyst Ratings
The average analyst rating for Outset Medical stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Reiterates $12 → $10 | Buy | Reiterates | $12 → $10 | +118.34% | May 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $8 → $6 | Buy | Reiterates | $8 → $6 | +31.00% | May 8, 2026 |
| RBC Capital | RBC Capital | Hold Reiterates $7 | Hold | Reiterates | $7 | +52.84% | May 8, 2026 |
| BTIG | BTIG | Buy Maintains $15 | Buy | Maintains | $15 | +227.51% | Feb 18, 2026 |
Financial Forecast
Revenue This Year
126.60M
from 119.48M
Increased by 5.96%
Revenue Next Year
140.37M
from 126.60M
Increased by 10.87%
EPS This Year
-2.89
from -4.30
EPS Next Year
-2.18
from -2.89
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 127.5M | 142.7M | |
| Avg | 126.6M | 140.4M | |
| Low | 125.0M | 139.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.7% | 12.7% | |
| Avg | 6.0% | 10.9% | |
| Low | 4.6% | 9.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.85 | -2.02 | |
| Avg | -2.89 | -2.18 | |
| Low | -2.92 | -2.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.